SCHEMBL23813151

SCHEMBL23813151

CC(C)Oc1ccccc1OC(F)F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
ACHE P22303 1/20 0.48
IRAK4 Q9NWZ3 1/20 0.47
NISCH Q9Y2I1 2/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
DRD1 P21728 1/20 0.42
ALOX12 P18054 1/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
TLR8 Q9NR97 1/20 0.39
MCHR1 Q99705 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2069775 0.87 ALDH1A1 (0.57) ALDH1A1ACHEIRAK4NISCHADRA2A
SCHEMBL29591819 0.87 ALDH1A1 (0.57) ALDH1A1ACHEIRAK4NISCHADRA2A
SCHEMBL4654255 0.87 DRD1 (0.48) ALDH1A1DRD1ALOX12KDM4EKMT2A
SCHEMBL9527314 0.81 CA1 (0.62) ALDH1A1ADRA2AADRA2BADRA2CKDM4E
SCHEMBL30041663 0.81 CA1 (0.62) ALDH1A1ADRA2AADRA2BADRA2CKDM4E
SCHEMBL28851801 0.80 ALDH1A1 (0.52) ALDH1A1ACHEIRAK4NISCHADRA2A
SCHEMBL105697 0.78 CA1 (0.65) ALDH1A1ACHEIRAK4NISCHADRA2A
SCHEMBL31433095 0.78 CA1 (0.65) ALDH1A1ACHEIRAK4NISCHADRA2A
SCHEMBL2737257 0.77 NISCH (0.46) ALDH1A1NISCHADRA2AADRA2BADRA2C
SCHEMBL17593428 0.77 IRAK4 (0.44) ALDH1A1ACHEIRAK4NISCHADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119351-A1 SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2022-04-21 US disclosed
WO-2021218997-A1 SUBSTITUTED FIVE-MEMBERED AZA-RING COMPOUND AND USE THEREOF IN DRUG 东莞市东阳光新药研发有限公司 2021-11-04 WO disclosed
EP-3590929-B1 SPIRO COMPOUND AND USE THEREOF MEDSHINE DISCOVERY INC (CN) 2021-09-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119351-A1 SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA7, CHRNA5, CHRNA2 ALDH1A1 1011/4885ACHE 29/4885IRAK4 631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.